Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
6.4
4.5
Journals
Microorganisms
Special Issues
Zoonotic Vector-Borne Pathogens
share announcement

Zoonotic Vector-Borne Pathogens

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Public Health Microbiology".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 2175

Special Issue Editor

Dr. Estela Escribano-Romero

E-Mail Website
Guest Editor
Department of Biotechnology, National Agricultural and Food Research and Technology Institute (INIA), 28040 Madrid, Spain
Interests: Virology (flavivirus; west nile virus; zika); host-virus interaction

Special Issue Information

Dear Colleagues,

The appearance and spread of emerging or reemerging pathogens, mostly zoonotic and/or transmitted by vectors, is an increasingly common phenomenon, being a continuous threat to public health, livestock and wildlife, especially in recent times when the ecology of many pathogens is changing due to global warming that is driving vector colonization of new geographic niches.

Zoonotic vector-borne pathogens are among the most important emerging pathogens. Their incidence is increasing in all regions of the world, and there are no specific treatments for most of these pathogens.

To address the problem of the emergence of zoonotic vector-borne pathogens and the significant challenge they represent, it is necessary to implement a comprehensive strategy that involves epidemiological surveillance, research, and interdisciplinary collaboration.

This Special Issue of Microorganisms will gather relevant articles reporting recent advances in the research on zoonotic vector-borne pathogens, from basic to translational studies. For this purpose, I invite you to submit research articles, review articles, and short communications covering different aspects of zoonotic vector-borne pathogens research, such as pathogen–host interactions, molecular and cell biology, immunology, diagnosis, vector biology and control, epidemiology, and the development of vaccines and drugs.

As a Guest Editor of this Special Issue, I look forward to reviewing your submissions and, together, defining the present state of science.

Dr. Estela Escribano-Romero
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • zoonosis
  • vector-borne pathogens
  • arbovirus
  • pathogen–host interaction molecular and cell biology
  • diagnosis
  • epidemiology
  • therapeutics

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 1528 KiB  
Article
Intrauterine Transmission of Zika and Vertical Transfer of Neutralizing Antibodies Detected Immediately at Birth in Oaxaca, Mexico: An Analysis in the Context of Microcephaly
by Alfredo Porras-García, Dina Villanueva-García, Rafael Arnaud-Rios, Nadia García-Lemus, Angélica Castillo-Romero, Mariana Mejía-Flores, Luis Erik Contreras, Liliana Hernández-Castillo, Elva Jiménez-Hernández, Juan Manuel Mejía-Aranguré, Sara A. Ochoa, Juan Xicothencatl-Cortes, Ariadnna Cruz-Córdova, Rosalia Lira-Carmona and José Arellano-Galindo
Microorganisms 2024, 12(3), 423; https://doi.org/10.3390/microorganisms12030423 - 20 Feb 2024
Viewed by 654
Abstract
Zika virus (ZIKV) can cause neurological issues in infants. To provide protection, neutralizing antibodies should be transferred from the mother to the infant. We conducted a study at the Hospital General de Pochutla, Oaxaca, Mexico. Samples were collected from mothers (blood and breast [...] Read more.
Zika virus (ZIKV) can cause neurological issues in infants. To provide protection, neutralizing antibodies should be transferred from the mother to the infant. We conducted a study at the Hospital General de Pochutla, Oaxaca, Mexico. Samples were collected from mothers (blood and breast milk) and infants (saliva and dried blood spots) within the first 12 postnatal hours (December 2017 to February 2018) and tested for ZIKV total and neutralizing antibodies as well as ZIKV-PCR. Microcephaly was evaluated according to INTERGROWTH-21st standards. Maternal IgG seroprevalence was 28.4% with 10.4% active infection, while infant IgG seroprevalence was 5.5% with 2.4% active infection. There were two cases of virolactia, and 6.3% of the infant saliva samples tested positive for ZIKV. Additionally, 18.3% of the infants were in a cephalic perimeter percentile lower than 10 and had an association between microcephaly and serology or a PCR between 8.6 and 60.9%. The infant blood samples had neutralizing antibodies, indicating intrauterine protection. Microcephaly was correlated with serology or PCR, but in our study population, non-ZIKV factors may be involved as well. Low ZIKV infection values in breast milk mean that breastfeeding is safe in most of the mothers and infants of the endemic area studied. Full article
(This article belongs to the Special Issue Zoonotic Vector-Borne Pathogens)
►▼ Show Figures

Figure 1

Review

Jump to: Research

13 pages, 1817 KiB  
Review
Hantavirus Pulmonary Syndrome Caused by Puumala Orthohantavirus—A Case Report and Literature Review
by Marija Santini, Jelena Ljubić, Nikola Šoštar, Tatjana Vilibić-Čavlek, Maja Bogdanić, Samo Zakotnik, Tatjana Avšič-Županc, Miša Korva, Ivan Christian Kurolt, Leona Radmanić, Petra Šimičić, Juraj Krznarić, Branimir Gjurašin, Marko Kutleša, Klaudija Višković, Nataša Cetinić Balent, Renata Žunec, Ivana Margeta Marić, Ana Ribarović and Snjezana Židovec-Lepej
Microorganisms 2023, 11(12), 2963; https://doi.org/10.3390/microorganisms11122963 - 12 Dec 2023
Viewed by 977
Abstract
In this article, we report on a rare case of acute respiratory distress syndrome (ARDS) caused by the Puumala orthohantavirus (PUUV), which is typically associated with hemorrhagic fever with renal syndrome (HFRS). This is the first documented case of PUUV-associated ARDS in Southeast [...] Read more.
In this article, we report on a rare case of acute respiratory distress syndrome (ARDS) caused by the Puumala orthohantavirus (PUUV), which is typically associated with hemorrhagic fever with renal syndrome (HFRS). This is the first documented case of PUUV-associated ARDS in Southeast Europe. The diagnosis was confirmed by serum RT-PCR and serology and corroborated by phylogenetic analysis and chemokine profiling. The patient was a 23-year-old male from Zagreb, Croatia, who had recently traveled throughout Europe. He presented with fever, headache, abdominal pain, and sudden onset of ARDS. Treatment involved high-flow nasal cannula oxygen therapy and glucocorticoids, which resulted in a full recovery. A systematic literature review identified 10 cases of hantavirus pulmonary syndrome (HPS) caused by PUUV in various European countries and Turkey between 2002 and 2023. The median age of patients was 53 years (range 24–73), and six of the patients were male. Most patients were treated in intensive care units, but none received antiviral therapy targeting PUUV. Eight patients survived hospitalization. The presented case highlights the importance of considering HPS in the differential diagnosis of ARDS, even in areas where HFRS is the dominant form of hantavirus infection. Full article
(This article belongs to the Special Issue Zoonotic Vector-Borne Pathogens)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop